eMed® Population Health Announces Appointment of Former X (Twitter) CEO Linda Yaccarino as new Chief Executive Officer

Yaccarino's hire will catalyze the company's growth as the recognized global leader in population health management

MIAMI, Aug. 5, 2025 /PRNewswire/ -- eMed Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced the appointment of Linda Yaccarino, former CEO of X (Twitter), as the company's new Chief Executive Officer.

Yaccarino's hiring is a game changing moment in eMed's mission to make safe, effective, and sustainable chronic care accessible directly through an all-in-one, digital-first experience. Her unparalleled experience in leading paradigm shifting transformations will bring a new dimension to the company.

Further, as the company expands its services to accommodate additional national and global employer and government partnerships, Yaccarino's years of experience will be instrumental in developing innovative programs focusing on the future of peptide population health management.

The eMed board of directors views Linda's arrival as a rare opportunity to bring on a dynamic CEO who turned around one of the most complex digital platforms in the world, and add a hands-on visionary who will accelerate the company's mission to revolutionize chronic care delivery. Her ability to forge game-changing partnerships and navigate complex markets will position the company to become the definitive global leader in population health solutions.

She is a highly sought-after leader who has a powerful presence and the undeniable ability to negotiate new partnerships, lead and drive transformational change, expand reach and increase eMed's ability to redefine healthcare outcomes throughout the world.

Prior to her CEO role at X (Twitter), Yaccarino was the chairman of global advertising and partnerships at NBCUniversal, where she oversaw all aspects of advertising, partnerships and strategic initiatives, and helped to create a global cross-sell platform that has become an industry standard. Throughout her career, she has helped numerous organizations navigate increasingly competitive and disruptive circumstances and create sustainable and winning positions.

A graduate of Penn State University, she has held many prestigious roles in her career and has been the recipient of countless industry awards. Her achievements include being recognized as one of the Top 10 People Transforming Advertising; one of the Ten Most Powerful Women in TV and Variety's Power Women of New York.

"The healthcare industry has been disrupted by technology, but not yet completely transformed by it. There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before," said Yaccarino. "To be a leader in today's healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry. We are very well-positioned to be that tenacious leader, striving toward our ultimate goal of improving global healthcare outcomes through our groundbreaking services and platforms."

eMed's population health program is being adopted across the world to provide safe, structured, and results-driven access to life-changing therapies that are making significant impact on population health outcomes. The company is actively expanding its market reach, provider network, data intelligence, and integrated behavioral health tools. Their digital-first population health management platform integrates at-home diagnostics, proctor-led screenings, physician-guided prescribing, and continuous adherence support, establishing a new standard for employee health benefits and government health programs globally.

About eMed
eMed® is the world's first end-to-end GLP-1/GIP care platform built on Empathetic AI™. From remote diagnostics and physician-led prescriptions to adherence coaching and clinical insights, eMed empowers employers to manage chronic disease with accountability and compassion. Learn more at www.eMed.com.

For Media Inquiries:
John Gonda
Sage Growth Partners
616-309-4888
[email protected]

SOURCE eMed